Literature DB >> 15629617

Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.

Ulrich Haedinger1, Thomas Krieger, Michael Flentje, Joern Wulf.   

Abstract

PURPOSE: To compare the pencil beam (PB) and collapsed cone (CC)-based three-dimensional dose calculation used for stereotactic irradiation of pulmonary targets. METHODS AND MATERIALS: Three-dimensional conformal dose distributions (using 6-MV and 18-MV photon beams) were generated for 33 pulmonary targets using the PB algorithm implemented in the Helax-TMS treatment planning system and then recalculated with the CC algorithm of TMS using an identical beam setup and parameters. The differences were analyzed by evaluating the dose-volume histograms for the planning target volume (PTV) and clinical target volume (CTV) and evaluating the computed absolute monitor units (MUs). The influence of the photon energy was also studied. For three cases, the results were compared with Monte-Carlo calculations.
RESULTS: Use of the CC model typically showed increased dose inhomogeneity. Owing to a more accurate modeling of secondary charged particle disequilibrium at the tumor-lung interface, the beam penumbra is broadened. The median and mean target dose decreased by 13.9% and 11.2% for the PTV and 9.2% and 9.4% for the CTV, respectively, using the CC algorithm. Consequently, the average PTV dose coverage decreased by 7.1% (SD, 6.5%). On average, the MUs calculated to achieve the prescribed dose were 5.4% (SD, 5.8%) greater for the CC algorithm. The difference in MUs between the PB and CC increased with decreasing PTV size and high photon energy (18 MV; r = -0.68), reaching 26% at the maximum.
CONCLUSION: The absorbed dose at the lung-tumor interface calculated by the PB algorithm was considerably greater than the dose calculated using the CC algorithm. In small targets (PTV < or = 100 cm(3)) and for 18-MV photons, the MUs calculated with PB may lead to an insufficient dose to the target volume.

Entities:  

Mesh:

Year:  2005        PMID: 15629617     DOI: 10.1016/j.ijrobp.2004.03.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.

Authors:  Jeho Jeong; Jung Hun Oh; Jan-Jakob Sonke; Jose Belderbos; Jeffrey D Bradley; Andrew N Fontanella; Shyam S Rao; Joseph O Deasy
Journal:  Clin Cancer Res       Date:  2017-05-24       Impact factor: 12.531

2.  CT-myelography for high-dose irradiation of spinal and paraspinal tumors with helical tomotherapy: revival of an old tool.

Authors:  Matthias Uhl; Florian Sterzing; Gregor Habl; Kai Schubert; Gabriele Sroka-Perez; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

3.  Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.

Authors:  J Koeck; Y Abo-Madyan; H T Eich; F Stieler; J Fleckenstein; J Kriz; R-P Mueller; F Wenz; F Lohr
Journal:  Strahlenther Onkol       Date:  2012-06-29       Impact factor: 3.621

4.  Evaluation of dose prediction errors and optimization convergence errors of deliverable-based head-and-neck IMRT plans computed with a superposition/convolution dose algorithm.

Authors:  I B Mihaylov; J V Siebers
Journal:  Med Phys       Date:  2008-08       Impact factor: 4.071

5.  Local control rates in stereotactic body radiotherapy (SBRT) of lung metastases associated with the biologically effective dose.

Authors:  Daniel Zucca Aparicio; Ovidio Hernando Requejo; Miguel Ángel de la Casa de Julián; Carmen Rubio Rodríguez; Pedro Fernández Letón
Journal:  Rep Pract Oncol Radiother       Date:  2019-01-22

6.  Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size.

Authors:  Fumiya Baba; Yuta Shibamoto; Hiroyuki Ogino; Rumi Murata; Chikao Sugie; Hiromitsu Iwata; Shinya Otsuka; Katsura Kosaki; Aiko Nagai; Taro Murai; Akifumi Miyakawa
Journal:  Radiat Oncol       Date:  2010-09-17       Impact factor: 3.481

7.  Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study.

Authors:  Antje Ernst-Stecken; Ulrike Lambrecht; Reinhold Mueller; Rolf Sauer; Gerhard Grabenbauer
Journal:  Strahlenther Onkol       Date:  2006-12       Impact factor: 3.621

8.  Optimization of extracranial stereotactic radiation therapy of small lung lesions using accurate dose calculation algorithms.

Authors:  Barbara Dobler; Cornelia Walter; Antje Knopf; Daniella Fabri; Rainer Loeschel; Martin Polednik; Frank Schneider; Frederik Wenz; Frank Lohr
Journal:  Radiat Oncol       Date:  2006-11-29       Impact factor: 3.481

9.  Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors.

Authors:  Masaru Narabayashi; Takashi Mizowaki; Yukinori Matsuo; Mitsuhiro Nakamura; Kenji Takayama; Yoshiki Norihisa; Katsuyuki Sakanaka; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-07-13       Impact factor: 2.724

10.  Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy.

Authors:  Anne Richter; Kurt Baier; Juergen Meyer; Juergen Wilbert; Thomas Krieger; Michael Flentje; Matthias Guckenberger
Journal:  BMC Med Phys       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.